A Study of Felzartamab in Participants With Lupus Nephritis
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Kenneth Kalunian
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSD
- Kenneth Kalunian
Professor Of Clinical, Medicine, Vc-health Sciences-schools. Authored (or co-authored) 203 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- HI-Bio, A Biogen Company
- ID
- NCT06064929
- Phase
- Phase 1/2 Lupus Research Study
- Study Type
- Interventional
- Participants
- Expecting 20 study participants
- Last Updated